Ramipril Substantially Improved Walking Times in PAD TrialRamipril Substantially Improved Walking Times in PAD Trial
After six months, patients with peripheral artery disease and intermittent claudication who were treated with ramipril were able to walk considerably longer pain free and walk much farther on a treadmill compared with their peers who received placebo, in a new study. Heartwire
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news
More News: Cardiology | Health | Heart | Intermittent Claudication | Pain | Peripheral Vascular Disease (PVD) | Study